Literature DB >> 25996620

Comparison of clinical prediction models for resistant bacteria in community-onset pneumonia.

Wesley H Self1, Richard G Wunderink2, Derek J Williams3, Tyler W Barrett1, Adrienne H Baughman1, Carlos G Grijalva4.   

Abstract

OBJECTIVES: Six recently published algorithms classify pneumonia patients presenting from the community into high- and low-risk groups for resistant bacteria. Our objective was to compare performance of these algorithms for identifying patients infected with bacteria resistant to traditional community-acquired pneumonia antibiotics.
METHODS: This was a retrospective study of consecutive adult patients diagnosed with pneumonia in an emergency department and subsequently hospitalized. Each patient was classified as high or low risk for resistant bacteria according to the following algorithms: original health care-associated pneumonia (HCAP) criteria, Summit criteria, Brito and Niederman strategy, Shorr model, Aliberti model, and Shindo model. The reference for comparison was detection of resistant bacteria, defined as methicillin-resistant Staphylococcus aureus or Gram-negative bacteria resistant to ceftriaxone or levofloxacin.
RESULTS: A total of 614 patients were studied, including 36 (5.9%) with resistant bacteria. The HCAP criteria classified 304 (49.5%) patients as high risk, with an area under the receiver operating characteristic curve (AUC) of 0.63 (95% confidence interval [CI] = 0.54 to 0.72), sensitivity of 0.69 (95% CI = 0.52 to 0.83), and specificity of 0.52 (95% CI = 0.48 to 0.56). None of the other algorithms improved both sensitivity and specificity or significantly improved the AUC. Compared to the HCAP criteria, the Shorr and Aliberti models classified more patients as high risk, resulting in higher sensitivity and lower specificity. The Shindo model classified fewer patients as high risk, with lower sensitivity and higher specificity.
CONCLUSIONS: All algorithms for identification of resistant bacteria included in this study had suboptimal performance to guide antibiotic selection. New strategies for selecting empirical antibiotics for community-onset pneumonia are necessary.
© 2015 by the Society for Academic Emergency Medicine.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25996620      PMCID: PMC4464985          DOI: 10.1111/acem.12672

Source DB:  PubMed          Journal:  Acad Emerg Med        ISSN: 1069-6563            Impact factor:   3.451


  42 in total

1.  A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.

Authors:  Takaya Maruyama; Takao Fujisawa; Masataka Okuno; Hirokazu Toyoshima; Kiyoyuki Tsutsui; Hikaru Maeda; Hisamichi Yuda; Masamichi Yoshida; Hiroyasu Kobayashi; Osamu Taguchi; Esteban C Gabazza; Yoshiyuki Takei; Naoyuki Miyashita; Toshiaki Ihara; Veronica Brito; Michael S Niederman
Journal:  Clin Infect Dis       Date:  2013-09-02       Impact factor: 9.079

2.  Community-acquired pneumonia versus healthcare-associated pneumonia. The returning pendulum.

Authors:  Richard G Wunderink
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

3.  Healthcare-associated pneumonia: where do we go next?

Authors:  Marcos I Restrepo; Stefano Aliberti
Journal:  Clin Infect Dis       Date:  2013-11-22       Impact factor: 9.079

Review 4.  Better tests, better care: improved diagnostics for infectious diseases.

Authors:  Angela M Caliendo; David N Gilbert; Christine C Ginocchio; Kimberly E Hanson; Larissa May; Thomas C Quinn; Fred C Tenover; David Alland; Anne J Blaschke; Robert A Bonomo; Karen C Carroll; Mary Jane Ferraro; Lisa R Hirschhorn; W Patrick Joseph; Tobi Karchmer; Ann T MacIntyre; L Barth Reller; Audrey F Jackson
Journal:  Clin Infect Dis       Date:  2013-12       Impact factor: 9.079

5.  Risk factors associated with nosocomial methicillin-resistant Staphylococcus aureus (MRSA) infection including previous use of antimicrobials.

Authors:  Eileen M Graffunder; Richard A Venezia
Journal:  J Antimicrob Chemother       Date:  2002-06       Impact factor: 5.790

6.  Health care--associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections.

Authors:  N Deborah Friedman; Keith S Kaye; Jason E Stout; Sarah A McGarry; Sharon L Trivette; Jane P Briggs; Wanda Lamm; Connie Clark; Jennifer MacFarquhar; Aaron L Walton; L Barth Reller; Daniel J Sexton
Journal:  Ann Intern Med       Date:  2002-11-19       Impact factor: 25.391

7.  Risk factors for drug-resistant pathogens in community-acquired and healthcare-associated pneumonia.

Authors:  Yuichiro Shindo; Ryota Ito; Daisuke Kobayashi; Masahiko Ando; Motoshi Ichikawa; Akira Shiraki; Yasuhiro Goto; Yasutaka Fukui; Mai Iwaki; Junya Okumura; Ikuo Yamaguchi; Tetsuya Yagi; Yoshimasa Tanikawa; Yasuteru Sugino; Joe Shindoh; Tomohiko Ogasawara; Fumio Nomura; Hideo Saka; Masashi Yamamoto; Hiroyuki Taniguchi; Ryujiro Suzuki; Hiroshi Saito; Takashi Kawamura; Yoshinori Hasegawa
Journal:  Am J Respir Crit Care Med       Date:  2013-10-15       Impact factor: 21.405

8.  Rates of emergency department visits due to pneumonia in the United States, July 2006-June 2009.

Authors:  Wesley H Self; Carlos G Grijalva; Yuwei Zhu; Candace D McNaughton; Tyler W Barrett; Sean P Collins; Alan B Storrow; Marie R Griffin
Journal:  Acad Emerg Med       Date:  2013-08-27       Impact factor: 3.451

Review 9.  Healthcare-associated pneumonia does not accurately identify potentially resistant pathogens: a systematic review and meta-analysis.

Authors:  James D Chalmers; Catriona Rother; Waleed Salih; Santiago Ewig
Journal:  Clin Infect Dis       Date:  2013-11-22       Impact factor: 9.079

10.  Delays in appropriate antibiotic therapy for gram-negative bloodstream infections: a multicenter, community hospital study.

Authors:  Rebekah W Moehring; Richard Sloane; Luke F Chen; Emily C Smathers; Kenneth E Schmader; Vance G Fowler; David J Weber; Daniel J Sexton; Deverick J Anderson
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

View more
  9 in total

1.  "Does this patient have…" "Is this patient at risk for infection with multidrug resistant bacteria?"

Authors:  Cristina Vazquez Guillamet; Marin H Kollef
Journal:  Intensive Care Med       Date:  2015-11-10       Impact factor: 17.440

Review 2.  Antimicrobial Stewardship in the Emergency Department.

Authors:  Michael Pulia; Robert Redwood; Larissa May
Journal:  Emerg Med Clin North Am       Date:  2018-09-06       Impact factor: 2.264

3.  Derivation and Multicenter Validation of the Drug Resistance in Pneumonia Clinical Prediction Score.

Authors:  Brandon J Webb; Kristin Dascomb; Edward Stenehjem; Holenarasipur R Vikram; Neera Agrwal; Kenneth Sakata; Kathryn Williams; Bruno Bockorny; Kavitha Bagavathy; Shireen Mirza; Mark Metersky; Nathan C Dean
Journal:  Antimicrob Agents Chemother       Date:  2016-04-22       Impact factor: 5.191

4.  Application of a Risk Score to Identify Older Adults with Community-Onset Pneumonia Most Likely to Benefit From Empiric Pseudomonas Therapy.

Authors:  Christopher R Frei; Sylvie Rehani; Grace C Lee; Natalie K Boyd; Erene Attia; Ashley Pechal; Rachel S Britt; Eric M Mortensen
Journal:  Pharmacotherapy       Date:  2017-02-03       Impact factor: 4.705

5.  Derivation and Validation of a Clinical Prediction Score to Identify the Isolation of Pseudomonas in Pneumonia.

Authors:  Yana Maskov; James M Sanders; Belen Tilahun; Sara A Hennessy; Joan Reisch; Meagan Johns
Journal:  Microbiol Spectr       Date:  2022-05-23

6.  Risk Factors and Outcomes for Ineffective Empiric Treatment of Sepsis Caused by Gram-Negative Pathogens: Stratification by Onset of Infection.

Authors:  Scott T Micek; Nicholas Hampton; Marin Kollef
Journal:  Antimicrob Agents Chemother       Date:  2017-12-21       Impact factor: 5.191

7.  Staphylococcus aureus Community-acquired Pneumonia: Prevalence, Clinical Characteristics, and Outcomes.

Authors:  Wesley H Self; Richard G Wunderink; Derek J Williams; Yuwei Zhu; Evan J Anderson; Robert A Balk; Sherene S Fakhran; James D Chappell; Geoffrey Casimir; D Mark Courtney; Christopher Trabue; Grant W Waterer; Anna Bramley; Shelley Magill; Seema Jain; Kathryn M Edwards; Carlos G Grijalva
Journal:  Clin Infect Dis       Date:  2016-05-08       Impact factor: 9.079

8.  A cohort study of bacteremic pneumonia: The importance of antibiotic resistance and appropriate initial therapy?

Authors:  Cristina Vazquez Guillamet; Rodrigo Vazquez; Jonas Noe; Scott T Micek; Marin H Kollef
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Validation of the prediction rules identifying drug-resistant pathogens in community-onset pneumonia.

Authors:  Daisuke Kobayashi; Yuichiro Shindo; Ryota Ito; Mai Iwaki; Junya Okumura; Toshihiro Sakakibara; Ikuo Yamaguchi; Tetsuya Yagi; Tomohiko Ogasawara; Yasuteru Sugino; Hiroyuki Taniguchi; Hiroshi Saito; Hideo Saka; Takashi Kawamura; Yoshinori Hasegawa
Journal:  Infect Drug Resist       Date:  2018-10-11       Impact factor: 4.003

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.